ABSTRACT
INTRODUCTION
Ttransrectal ultrasound guided biopsy prostate biopsy, despite its limitations, remains is the standard procedure to confirm the diagnosis of prostate cancer [1] . Infective complications of TRUS biopsy are well recognized, ranging from bacteriuria, UTI and epididymitis to septic shock, with 1.3% admission rate for sepsis in the UK [2] . Immunocompromised patients are considered to be at a higher than average risk of infection. Septic portal vein thrombosis (pylephlebitis) is rarely associated with intra-abdominal sepsis, including appendicitis and diverticulitis [3] . On literature review, only one case report of pylephlebitis after TRUS biopsy was identified [4] .
CASE REPORT
A 66-year-old non-smoker with a background of myeloproliferative disorder and asthma on long-term oral steroids was admitted with symptoms of intraabdominal sepsis. Contrast CT and splenic ultrasound revealed enlarged and congested spleen due to thrombus in the distal splenic vein (Figure 1 ), an occluded portal vein with thrombus extending to the distal splenic vein and two splenic fluid collections measuring 7.1x6.8 cm and 2.8x2.7 cm (Figure 2 ).
History revealed that patient has not been well since he underwent TRUS prostate biopsy for an elevated prostate specific antigen (PSA) six weeks earlier.
Pre-procedure MRI demonstrated no overt signs of malignancy (PI-RADs score of II). He received standard antibiotic prophylaxis for prostate biopsy, consisting of ciprofloxacin, metronidazole and gentamicin.
Following the biopsy, patient developed a number of non-specific symptoms, including malaise, lethargy, bilateral leg oedema and vague abdominal pain. He thought emergency medical help three times in the previous six weeks. Firstly, he was treated for what was thought to be bilateral leg cellulitis with three different courses of antibiotics. Then he re-presented with abdominal pain owing to presumed ureteric colic and was reassured after normal non-contrast CT KUB. Soon after, he came back with worsening abdominal pain and obvious symptoms of int abdominal sepsis.
Systemic sepsis raised concerns about the risk of splenic abscess from pylephlebitis and portal pyemia secondary to the prostate biopsy, taking into account that his immunocompromised state and being on longterm steroids may have been the predisposing factors. Multidisciplinary team managing the patient included the admitting surgical team, urology, microbiology, hematology and interventional radiology.
Conservative management strategy was chosen. Included intravenous antibiotics with 1.2 gm of Coamoxiclav for 12 days and 350 mg of Gentamicin as stat dose on admission, followed by 625 mg of oral Coamoxiclav on discharge for 9 days with full anticoagulation using heparin. Splenectomy was discussed, but this was left as a salvage option in case of failure to progress, taking into consideration splenectomy risks in the patient with myeloproliferative disorder. Patient underwent ultrasound-guided aspiration of splenic collections, which yielded some altered blood. Patient's symptoms had completely resolved and inflammatory markers normalized after 10 days of hospitalization. Oral anticoagulation (Rivaroxaban) prescribed on home discharge and follow up was arranged with the hematologist, vascular surgeon and the urologist. 
Outcome and follow up
When the patient was reviewed in the clinic later, he had achieved the full recovery. Follow up ultrasound showed a small area of infarction within the spleen, partial recanalization of the main portal vein with a total recanalization of the intrahepatic veins and recanalization of the splenic vein (Figures 3 and 4) . Hydroxycarbamide was discussed with patient as a future option for the essential thrombocytosis. From the urology perspective, prostate biopsy histology showed microacinar adenocarcinoma in 1 of 16 cores (Gleason pattern 3 + 4); patient was enlisted on active surveillance programme.
DISCUSSION
Infective complications of TRUS biopsy are well recognized. The presumed mechanism is the direct inoculation of the prostatic tissue and blood by a needle traversing the rectal mucosa, with multi-resistant Escherichia coli as the pathogen most commonly associated. Antimicrobial prophylaxis is unanimously recommended for TRUS prostate biopsy. However, even with prophylaxis, sepsis after TRUS is increasingly becoming a significant burden worldwide [5] .
A number of patient and procedure specific factors have an association with increased sepsis rates after TRUS biopsy: existence of multi-resistant bowel flora in patients with multiple previous courses of antibiotic treatment, healthcare exposure and/or history of frequent international travel, comorbidities and regular intake of non-steroidal anti-inflammatory medications [5] .
Strategies to minimize the risk of sepsis after prostate biopsy include targeted prophylaxis with a prior rectal swab and transperineal biopsy route, which is associated with a much lower sepsis risk [5] .
Immune compromised patients are at increased risk of sepsis after prostate biopsy, as in this patient a combination of JAK2 positive myeloproliferative disorder and being on oral long-term steroids for asthma have contributed to the development of this rare complication, which was reported only once previously [4] .
Furthermore, essential thrombocytosis associated with JAK2 positive myeloproliferative disorder has been associated with portal and splenic vein thrombosis [6] . While splenectomy was considered in the early course of treatment, therapeutic splenectomy in a patient with myeloproliferative disorder can be complicated by thrombotic events and bone marrow dysplasia, also patient will need increased doses of drugs which may enhance leukemic transformation [7] .
On the other hand, conservative treatment with antibiotics, anticoagulation and ultrasound-guided aspiration was an effective strategy, which led to a complete resolution of the infection and thrombosis.
CONCLUSION
The immune compromised patients requiring evaluation with a prostate biopsy, would benefit from a transperineal rather than transrectal prostate biopsy. Furthermore, an individual antibiotic prophylaxis strategy should be discussed with a microbiologist. 
